AVG-233

• Description:

  AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 replication.AVG-233 is used in the study of respiratory syncytial virus infections.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  487.94

• Molecular Formula:

  C26H22ClN5O3

• Notes:

  Research use only, not for human use.

• Receptor:

  DNA/RNA Synthesis | RSV

• CAS Number:

  2151937-80-1